Loading news...
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE), will hold an Investor Day at the Nasdaq MarketSite in New York City on Monday, November 17th 2025. The event will begin at 2:00pm ET and will include presentations by members of the management team.
Keystone is expected to generate approximately $65 million of revenue and approximately $13 million of Adjusted EBITDA (1) in the full-year 2025, with revenue expected to grow more than 50% in 2025 versus 2024 Acquisition follows multi-year partnership between Strata and Keystone whereby Keystone has successfully recovered hundreds of organs on behalf of Strata customers $124 million acquisition represents an approximate 9x multiple of 2025 estimated Adjusted EBITDA (1) ; Keystone's go forward Free Cash Flow (1) conversion is expected to be approximately 80% NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE), today announced that it has completed the acquisition of Keystone Perfusion Services LLC ("Keystone"), one of the largest organ recovery and normothermic regional perfusion ("NRP") service providers to the transplant industry and an industry leader in perfusion and other critical medical solutions for hospitals in non-transplant surgeries nationwide.
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE) today announced that Will Heyburn, Co-Chief Executive Officer and Chief Financial Officer, will present at the 2025 Jefferies Industrials Conference on Thursday, Sept 4, 2025 at 11:30am ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/news-events.
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), today confirmed that the previously announced change of its legal name to Strata Critical Medical, Inc is expected to occur this week. The change is intended to reflect the Company's plan to focus on providing mission critical logistics and medical services to hospitals and healthcare providers throughout the country following the closing of the previously announced agreement to sell Blade's Passenger business to Joby Aviation, Inc. (NYSE: JOBY).
Joby Aviation (JOBY -3.55%) has had an incredible year so far. As of this writing on Aug. 18, 2025, the electric vertical take-off and landing (eVTOL) aircraft pioneer has jumped by 105% compared to the S&P 500's 9.7% gain. However, with the pre-revenue eVTOL company boasting a market cap exceeding $14 billion and no significant revenue streams on the near-term horizon, it's prudent to consider whether this high-flying stock remains a worthwhile investment. Let's take a closer look to find out. Joby just achieved what no other eVTOL company has done: completing the first piloted electric air taxi flight between two public airports. The 12-minute journey from Marina to Monterey, California demonstrated the aircraft's ability to operate in FAA-controlled airspace alongside commercial jets. The company even had to hold for five minutes to let an airliner land first -- proof that these aren't just expensive toys but legitimate aircraft ready for the real world. The operational momentum is undeniable. Joby is 70% complete on its side of FAA-type certification, with the agency itself over 50% finished. The company completed 21 full-transition flights in Dubai this summer, testing in 110-degree heat to validate commercial readiness. Manufacturing capacity is expanding too, with the 435,000 square-foot Marina plant capable of producing roughly 24 aircraft per year at initial scale. But here's the reality check: Joby's second-quarter financials tell a different story. The company reported a net loss of $325 million on revenue of just $15,000 in Q2 -- essentially zero for a company of this size. Even adjusting for non-cash items, the operating loss was $168 million. Management expects to burn between $500 million and $540 million in 2025, which implies well over $100 million per quarter at the current pace. Wall Street's consensus has Joby generating only about $232,000 in revenue for all of 2025 -- less than $60,000 per quarter on average -- underscoring just how far the valuation is running ahead of fundamentals. Toyota (TM 2.15%) clearly believes in Joby's vision, closing the first $250 million tranche of a promised $500 million investment. This isn't just financial support -- it's automotive manufacturing expertise that could prove invaluable when Joby needs to scale from prototypes to mass production. The company ended Q2 with $991 million in cash and equivalents, enough for less than two years of runway at the midpoint of guidance. Joby is also making smart strategic moves. The planned acquisition of Blade Air Mobility's passenger business for up to $125 million in cash and stock gives immediate access to existing helicopter routes and infrastructure in New York City -- essentially buying a customer base and operational blueprint. The new partnership with L3Harris to develop gas turbine hybrid variants opens defense opportunities that could generate revenue before passenger operations begin. These aren't desperate pivots; they're calculated expansions of the business model. Defense contracts don't require the same regulatory approvals as passenger service. Existing helicopter routes prove demand for urban air mobility exists at premium price points. Every move reduces execution risk while expanding the addressable market. Joby represents everything exciting about the future of transportation. The technology works, the partnerships are real, and the market opportunity could be massive. CEO JoeBen Bevirt has been working on this vision for over a decade, and the company has logged more than 40,000 flight miles -- this isn't vaporware. But at its current premium valuation, the stock assumes near-perfect execution over the next several years. Any regulatory slip, manufacturing stumble, or safety incident could spark a brutal repricing. The company won't generate meaningful revenue until at least 2028, and Wall Street's consensus actually has net losses widening through 2027 as business development and capital expenditures ramp up. Even optimistic analysts don't model cash-flow breakeven before 2028 to 2030. For believers in urban air mobility, Joby might be worth a small speculative position after its bull run this year. The company has the technology, partnerships, and capital to potentially pull this off. But for most investors, waiting for commercial operations to actually begin -- and for the valuation to reflect reality rather than dreams -- seems like the prudent flight path. Sometimes the smartest move is accepting you may have already missed the flight.
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), a technology-powered air mobility platform, today announced that Will Heyburn, Chief Financial Officer, will present at the Oppenheimer 28th Annual Technology, Internet & Communications Conference on Monday, August 11, 2025 at 2:55pm ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.blade.com/news-events.
It's been quite the week for Blade Air Mobility Inc. NASDAQ: BLDE. On August 4, Blade and Joby Aviation Inc. NYSE: JOBY announced the sale of Blade's passenger mobility business to Joby for up to $125 million.
Blade (BLDE) Q2 Revenue Jumps 10%
Blade Air Mobility sold its passenger/UAM division to Joby Aviation, shifting focus to medical organ transport and rebranding as Strata Critical Medical. The deal improves Blade's capital position but sacrifices the higher-growth air taxi opportunity, disappointing original investment expectations. Strata now controls 30% of the organ logistics market, with strong growth, solid profitability, and trades at an attractive valuation below 1x sales.
Blade Air Mobility, Inc. (NASDAQ:BLDE ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants Mathew Schneider - Vice President of Investor Relations & Strategic Finance Melissa M. Tomkiel - President, General Counsel & Corporate Secretary Robert S.
Blade Air Mobility, Inc. (BLDE) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.06 per share a year ago.
Medical revenue increased 17.6% year-over-year in Q2 2025 Net loss improved by $7.6 million versus the prior year to $(3.7) million in Q2 2025; Adjusted EBITDA improved by $2.2 million versus the prior year to $3.2 million in Q2 2025 (1) Blade Passenger division to be sold to Joby Aviation for up to $125 million; Blade's Medical division will remain a standalone public company, rebrand as Strata Critical Medical ("Strata") Sale is expected to be Adjusted EBITDA and Free Cash Flow neutral on a go forward basis NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, "Blade" or the "Company"), today announced financial results for the second quarter ended June 30, 2025. GAAP FINANCIAL RESULTS (in thousands except percentages, unaudited) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 % Change 2025 2024 % Change Revenue $ 70,801 $ 67,945 4.2 % $ 125,107 $ 119,459 4.7 % Cost of revenue $ 53,064 $ 51,591 2.9 % $ 95,392 $ 92,966 2.6 % Software development 915 971 (5.8 ) % 1,727 1,641 5.2 % General and administrative 20,142 25,136 (19.9 ) % 37,456 42,345 (11.5 ) % Selling and marketing 1,634 2,396 (31.8 ) % 3,069 4,524 (32.2 ) % Total operating expenses $ 75,755 $ 80,094 (5.4 ) % $ 137,644 $ 141,476 (2.7 ) % Loss from operations $ (4,954 ) $ (12,149 ) (59.2 ) % $ (12,537 ) $ (22,017 ) (43.1 ) % Net loss $ (3,743 ) $ (11,326 ) (67.0 ) % $ (7,236 ) $ (15,560 ) (53.5 ) % Gross profit $ 12,889 $ 11,336 13.7 % $ 20,982 $ 17,188 22.1 % Gross margin 18.2 % 16.7 % 150bps 16.8 % 14.4 % 240bps NON-GAAP (1) FINANCIAL RESULTS (in thousands except percentages, unaudited) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 % Change 2025 2024 % Change Revenue $ 70,801 $ 67,945 4.2 % $ 125,107 $ 119,459 4.7 % Cost of revenue 53,064 51,591 2.9 % 95,392 92,966 2.6 % Flight Profit 17,737 16,354 8.5 % 29,715 26,493 12.2 % Flight Margin 25.1 % 24.1 % 100bps 23.8 % 22.2 % 160bps Adjusted SG&A 15,399 15,834 (2.7 )% 29,370 29,602 (0.8 )% Depreciation included in cost of revenue 852 438 NM(2) 1,607 521 NM(2) Adjusted EBITDA $ 3,190 $ 958 233.0 % $ 1,952 $ (2,588 ) NM(2) Adjusted EBITDA as a percentage of Revenue 4.5 % 1.4 % 310bps 1.6 % (2.2 )% NM(2) Passenger Adjusted EBITDA $ 2,389 $ 782 205.5 % $ 2,443 $ (1,869 ) NM(2) Medical Adjusted EBITDA $ 6,039 $ 5,524 9.3 % $ 10,137 $ 9,933 2.1 % Adjusted unallocated corporate expenses and software development $ (5,238 ) $ (5,348 ) (2.1 )% $ (10,628 ) $ (10,652 ) (0.2 )% (1) See "Use of Non-GAAP Financial Information" and "Key Metrics and Non-GAAP Financial Information" sections attached to this release for an explanation of Non-GAAP measures used and reconciliations to the most directly comparable GAAP financial measure.
Note: JOBY is buying Blade Air Mobility, Inc. BLDE, an “Uber for helicopters”, causing JOBY shares to spike 21% intraday. I'm not going to chase the stock here.
Shares of Joby Aviation Inc (NYSE:JOBY) soared this morning after the company announced its acquisition of fellow aviation name Blade Air Mobility's (BLDE) helicopter ride-share business for $125 million.
Joby Aviation is attractive among eVTOL stocks due to strong certification progress and a clear path to commercial service entry. Acquiring Blade Air Mobility would give Joby instant access to booking platforms, operating certificates, and crucial infrastructure for air taxi rollout. Blade's partnerships and exclusive terminal access would accelerate Joby's eVTOL deployment, reducing the need for heavy infrastructure investments.
Electric air taxi developer Joby Aviation has agreed to buy Blade Air Mobility's helicopter ride-share business for as much as $125 million.
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”) today announced an agreement to sell Blade's passenger division to Joby Aviation, Inc. (NYSE: JOBY) for up to $125 million.
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), will release financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 before the market opens. The company will hold a conference call the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Rob Wiesenthal, Blade's Chief Executive Officer, and Will Heyburn, Blade's Chief Financial Officer, and will include a question-and-answer session for call participants.
Blade Air Mobility is well-positioned for the eVTOL-driven UAM market, with an asset-light model and multiple manufacturer partnerships. The Trump Executive Order accelerates eVTOL integration, but its immediate impact on Blade is limited beyond potential certification speed-up. Blade's current valuation is attractive, trading at just 1x EV/S, with significant upside once eVTOLs unlock the $1+ billion TAM.
Does Blade Air Mobility, Inc. (BLDE) have what it takes to be a top stock pick for momentum investors? Let's find out.